Kazuho Miyashita

Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era

Reina Watanabe, Naoto Tomita, Megumi Itabashi et al. · European Journal Of Haematology · 2013 · 57 citations

Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy

Kazuho Miyashita, Naoto Tomita, Masataka Taguri et al. · Leukemia Research · 2015 · 34 citations

Medicine, Hematology, Immunology +5

Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

Taiki Ando, Shin Fujisawa, Haruka Teshigawara et al. · International Journal of Hematology · 2020 · 27 citations

Transplantation, Medical Imaging, Nonrelapse Mortality +9

R‐<scp>CHOP</scp> therapy alone in limited stage diffuse large B‐cell lymphoma

Naoto Tomita, Hirotaka Takasaki, Kazuho Miyashita et al. · British Journal of Haematology · 2013 · 25 citations · Full text

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Reina Watanabe, Naoto Tomita, Kumiko Kishimoto et al. · Leukemia Research · 2013 · 19 citations

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +11